Thermo Fisher Scientific Inc.
TMO· NYSE
Filed Jul 31, 2020 · 10-Q · 34 days after period end · 0000097745-20-000038
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Revenue | $6.92B | $6.32B | $6.08B | $4.99B |
| EPS Diluted | $2.90 | $2.77 | $1.85 | $1.56 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
ended Jun 27, 2020 · filed Jul 31, 2020 · 34 d after period end